Periperative infliximab and/or immunomodulator therapy is not associated with increased postoperative complications in Crohn's disease

Periperative infliximab and/or immunomodulator therapy is not associated with increased postoperative complications in Crohn's disease

Saved in:
Bibliographic Details
Published in:Gastroenterology (New York, N.Y. 1943) Vol. 124; no. 4; p. A521
Main Authors: Colombel, Jean F., Loftus, Edward V., Tremaine, William J., Pemberton, John H., Wolff, Bruce G., Young-Fadok, Tonia, Harmsen, William S., Schleck, Cathy G., Sandborn, William J.
Format: Journal Article
Language:English
Published: Elsevier Inc 01-04-2003
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0016-5085
1528-0012
DOI:10.1016/S0016-5085(03)82635-5